Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Clinical trial NCT00280878 · COMPLETED

Trial details

NCT number: NCT00280878
Sponsor: Bayside Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (CD20+)

Start date: 2006-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.